Zhejiang CONBA Pharmaceutical Co Ltd (600572) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥133.43 Million ≈ $19.52 Million USD) by net assets (CN¥7.16 Billion ≈ $1.05 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang CONBA Pharmaceutical Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Zhejiang CONBA Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Zhejiang CONBA Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Zhejiang CONBA Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang CONBA Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Atalaya Mining Ltd
F:E5S1
|
0.122x |
|
Concentrix Corporation
NASDAQ:CNXC
|
-0.030x |
|
Borregaard ASA
OL:BRG
|
0.071x |
|
Zhejiang Dayuan Pumps Ind Co
SHG:603757
|
-0.003x |
|
Paradeep Phosphates Limited
NSE:PARADEEP
|
0.024x |
|
Shenzhen Kingdom SCI Tech Co Ltd
SHG:600446
|
0.005x |
|
Harmonic Inc
NASDAQ:HLIT
|
0.089x |
|
Peker Gayrimenkul Yatirim Ortakligi AS
IS:PEKGY
|
0.126x |
Annual Cash Flow Conversion Efficiency for Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang CONBA Pharmaceutical Co Ltd from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see 600572 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥7.15 Billion ≈ $1.05 Billion |
CN¥942.61 Million ≈ $137.93 Million |
0.132x | -10.02% |
| 2024-12-31 | CN¥6.91 Billion ≈ $1.01 Billion |
CN¥1.01 Billion ≈ $148.16 Million |
0.146x | +19.80% |
| 2023-12-31 | CN¥7.35 Billion ≈ $1.08 Billion |
CN¥898.64 Million ≈ $131.50 Million |
0.122x | -22.50% |
| 2022-12-31 | CN¥7.32 Billion ≈ $1.07 Billion |
CN¥1.16 Billion ≈ $169.08 Million |
0.158x | +31.05% |
| 2021-12-31 | CN¥7.39 Billion ≈ $1.08 Billion |
CN¥889.94 Million ≈ $130.23 Million |
0.120x | -48.47% |
| 2020-12-31 | CN¥5.35 Billion ≈ $782.79 Million |
CN¥1.25 Billion ≈ $182.87 Million |
0.234x | +24.76% |
| 2019-12-31 | CN¥4.94 Billion ≈ $723.27 Million |
CN¥925.50 Million ≈ $135.43 Million |
0.187x | +98.73% |
| 2018-12-31 | CN¥5.79 Billion ≈ $847.64 Million |
CN¥545.78 Million ≈ $79.86 Million |
0.094x | -22.70% |
| 2017-12-31 | CN¥5.84 Billion ≈ $855.11 Million |
CN¥712.27 Million ≈ $104.23 Million |
0.122x | -43.59% |
| 2016-12-31 | CN¥4.49 Billion ≈ $656.77 Million |
CN¥969.71 Million ≈ $141.90 Million |
0.216x | +18.66% |
| 2015-12-31 | CN¥4.57 Billion ≈ $668.05 Million |
CN¥831.26 Million ≈ $121.64 Million |
0.182x | -0.61% |
| 2014-12-31 | CN¥3.37 Billion ≈ $493.18 Million |
CN¥617.43 Million ≈ $90.35 Million |
0.183x | +101.72% |
| 2013-12-31 | CN¥2.59 Billion ≈ $379.22 Million |
CN¥235.36 Million ≈ $34.44 Million |
0.091x | -9.81% |
| 2012-12-31 | CN¥2.44 Billion ≈ $357.14 Million |
CN¥245.76 Million ≈ $35.96 Million |
0.101x | -13.82% |
| 2011-12-31 | CN¥1.61 Billion ≈ $235.90 Million |
CN¥188.36 Million ≈ $27.56 Million |
0.117x | +59.22% |
| 2010-12-31 | CN¥1.72 Billion ≈ $251.12 Million |
CN¥125.93 Million ≈ $18.43 Million |
0.073x | -45.11% |
| 2009-12-31 | CN¥1.15 Billion ≈ $167.90 Million |
CN¥153.39 Million ≈ $22.45 Million |
0.134x | +24.75% |
| 2008-12-31 | CN¥919.66 Million ≈ $134.58 Million |
CN¥98.56 Million ≈ $14.42 Million |
0.107x | +14.52% |
| 2007-12-31 | CN¥854.74 Million ≈ $125.08 Million |
CN¥79.98 Million ≈ $11.70 Million |
0.094x | -17.51% |
| 2006-12-31 | CN¥627.66 Million ≈ $91.85 Million |
CN¥71.20 Million ≈ $10.42 Million |
0.113x | -42.62% |
| 2005-12-31 | CN¥595.08 Million ≈ $87.08 Million |
CN¥117.65 Million ≈ $17.22 Million |
0.198x | +70.62% |
| 2004-12-31 | CN¥565.05 Million ≈ $82.68 Million |
CN¥65.47 Million ≈ $9.58 Million |
0.116x | -58.37% |
| 2003-12-31 | CN¥239.44 Million ≈ $35.04 Million |
CN¥66.64 Million ≈ $9.75 Million |
0.278x | -- |
About Zhejiang CONBA Pharmaceutical Co Ltd
Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nut… Read more